Literature DB >> 19470871

Triple fixed-dose combination therapy: back to the past.

Henry R Black.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19470871     DOI: 10.1161/HYPERTENSIONAHA.109.132688

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  11 in total

Review 1.  Aliskiren, amlodipine and hydrochlorothiazide triple combination for hypertension.

Authors:  Eric Judd; Edgar A Jaimes
Journal:  Expert Rev Cardiovasc Ther       Date:  2012-03

2.  Role of triple fixed combination valsartan, amlodipine and hydrochlorothiazide in controlling blood pressure.

Authors:  Monica Doménech; Antonio Coca
Journal:  Patient Prefer Adherence       Date:  2010-05-13       Impact factor: 2.711

Review 3.  Rationale for triple-combination therapy for management of high blood pressure.

Authors:  Alan H Gradman
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-08-20       Impact factor: 3.738

Review 4.  The efficacy and safety of triple vs dual combination of angiotensin II receptor blocker and calcium channel blocker and diuretic: a systematic review and meta-analysis.

Authors:  Pinar Kizilirmak; Mehmet Berktas; Yagiz Uresin; Okan Bulent Yildiz
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-12-14       Impact factor: 3.738

5.  Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination.

Authors:  Michael B Hovater; Edgar A Jaimes
Journal:  Integr Blood Press Control       Date:  2013-06-14

6.  Combined olmesartan, amlodipine, and hydrochlorothiazide therapy in randomized patients with hypertension: a subgroup analysis of the TRINITY study by age.

Authors:  Andrew J Lewin; Joseph L Izzo; Michael Melino; James Lee; Victor Fernandez; Reinilde Heyrman
Journal:  Drugs Aging       Date:  2013-07       Impact factor: 3.923

Review 7.  Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approaches.

Authors:  Thomas Unger; Ludovit Paulis; Domenic A Sica
Journal:  Eur Heart J       Date:  2011-09-27       Impact factor: 29.983

Review 8.  Renal denervation: ultima ratio or standard in treatment-resistant hypertension.

Authors:  Alexandre Persu; Jean Renkin; Lutgarde Thijs; Jan A Staessen
Journal:  Hypertension       Date:  2012-07-30       Impact factor: 10.190

Review 9.  A review of the efficacy and tolerability of combination amlodipine/valsartan in non-white patients with hypertension.

Authors:  Keith C Ferdinand; Samar A Nasser
Journal:  Am J Cardiovasc Drugs       Date:  2013-10       Impact factor: 3.571

10.  Single-Pill Combination of Perindopril/Indapamide/Amlodipine in Patients with Uncontrolled Hypertension: A Randomized Controlled Trial.

Authors:  Sergey V Nedogoda; Vesna J Stojanov
Journal:  Cardiol Ther       Date:  2017-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.